Tag: Gut Inflammation

Inflammatory Bowel Disease (IBD), encompassing conditions like Crohn’s disease and Ulcerative Colitis, represents a profound disruption of intestinal homeostasis. Traditional pharmacological approaches often rely on systemic immunosuppressants, which carry significant risks of infection and long-term toxicity. In the search for highly targeted, localized anti-inflammatory agents, peptide research has increasingly focused on KPV (Lysine-Proline-Valine). This naturally […]